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ABSTRACT
Introduction  Renal function is reported using the estimates of glomerular filtra-
tion rate (eGFR). However, eGFR values are recorded without reference to the par-
ticular serum creatinine (SCr) assays used to derive them, and newer assays were 
introduced at different time points across the laboratories in the United Kingdom. 
These changes may cause systematic bias in eGFR reported in routinely col-
lected data, even though laboratory-reported eGFR values have a correction factor 
applied.
Design An algorithm to detect changes in SCr that in turn affect eGFR calculation 
method was developed. It compares the mapping of SCr values on to eGFR values 
across a time series of paired eGFR and SCr measurements.
Setting Routinely collected primary care data from 20,000 people with the richest 
renal function data from the quality improvement in chronic kidney disease trial.
Results  The  algorithm  identified  a  change  in  eGFR calculation method  in  114 
(90%) of the 127 included practices. This change was identified in 4736 (23.7%) 
patient time series analysed. This change in calibration method was found to cause 
a significant step change in the reported eGFR values, producing a systematic bias. 
The eGFR values could not be recalibrated by applying the Modification of Diet in 
Renal Disease equation to the laboratory reported SCr values.
Conclusions This algorithm can identify laboratory changes in eGFR calculation 
methods and changes in SCr assay. Failure to account for these changes may mis-
construe renal function changes over time. Researchers using routine eGFR data 
should account for these effects.
Keywords: assay methods, estimates of glomerular filtration rate (eGFR), 
serum creatinine (SCr).
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INTRODUCTION
Chronic kidney disease  (CKD)  is a significant public health 
problem and is becoming more common with the ageing 
population and increasing disease burden from diabetes.1,2 
There is a complex relationship between CKD, diabetes, and 
hypertension resulting in increased risk of mortality and car-
diovascular disease in people with these commonly comorbid 
conditions.3 Recent estimates of the prevalence of CKD in the 
United Kingdom are around 7.3%–8.5%.4,5 This is associated 
with substantial financial burden:  in 2009–2010,  the cost of 
CKD to the English National Health Service (NHS) was esti-
mated at £1.44–£1.45 billion, approximately 1.3% of the total 
NHS spending during this period.6 Over half of this was spent 
on renal replacement therapy for people with end-stage renal 
disease, which accounts for only 2% of the CKD population.6 
Early  identification,  appropriate  referral,  and  intervention  in 
CKD are therefore critically important.
Estimation  of  renal  function  has  been  routine  in  clinical 
practice since the publication of the Cockcroft–Gault equation 
for estimating creatinine clearance  in 1976.7 Categorisation 
of  CKD  and  clinical  decisions  are  currently  based  on  the 
estimated  glomerular  filtration  rate  (eGFR)8,9 although the 
Cockcroft–Gault  equation  is  still  widely  used  to  calculate 
drug dosing.10,11 The eGFR can be calculated from serum 
creatinine (SCr) measurements using the Modification of Diet 
in Renal Disease (MDRD) equation first published in 199912 
and later simplified in 2003.13 However, the MDRD equation 
underestimates GFR in people with mild renal impairment14,15 
and in some subgroups, such as kidney donors and peo-
ple with diabetes.16,17 More recently,  the CKD Epidemiology 
Collaboration  (CKD-EPI)  equation was developed  to  tackle 
these limitations and has been demonstrated to have 
improved performance in mild renal impairment and across 
patient subgroups.18–21
Continuously changing methods for calculating renal 
function present a problem for both clinicians and research-
ers. Changing methods of eGFR calculation affect trends 
in renal function over a period of years. This problem 
is further compounded by differing creatinine assays 
between laboratories.22,23 The UK National External Quality 
Assessment Scheme  (UKNEQAS)  recommends  that  each 
clinical laboratory calculate eGFR using isotope dilution 
mass  spectrometry  (IDMS)  creatinine  assay,  a  standardi-
sation program that was initiated in 2007,24,25 with different 
laboratories achieving standardisation at different times 
(Figure 1). In clinical practice, laboratory-calculated eGFR 
values are reported without reference to the equations or 
creatinine assays that were used to derive them. Records 
will also contain eGFR results derived in practice possibly 
using one of the many online calculators.25 In our experi-
ence, this practice was most common when primary care 
first became aware of CKD, but is now rare, with the auto-
matic reporting of eGFR and creatinine.
Current clinical guidelines recommend early refer-
ral of patients with declining GFR to specialist services. 
While standardisation of current eGFR values has been 
achieved, there is a need for retrospective calibration both 
in the research and the clinical settings to allow accurate 
monitoring of renal function trends. If the CKD-EPI equation 
is widely adopted in primary care, this will be of renewed 
importance.26 Here, we describe a method for identifying 
changes in eGFR calculation method (which includes cor-
rection factors for the creatinine assay used) in routinely col-
lected data.  Identification of  these changes  is the first step 
towards backward calibration of the entire eGFR time series 
for a given patient – that is, making all of the patient’s eGFR 
measurements compatible. Without such a method, trends 
in renal function are misleading. Our algorithm identifies the 
date of change from one method eGFR calculation method 
to the next for each patient and primary care practice. While 
this has little immediate clinical importance or relevance, 
there are substantial implications for longitudinal research 
utilising these historical data.
METHOD
The UK electronic patient record is currently coded using the 
read coding system.27 This enables coding of the eGFR equa-
tion used, although eGFR can be coded with no reference to 
the equation used. We investigated the range of codes avail-
able to record eGFR to explore if there was scope to improve 
the provenance of these data.
We devised an algorithm that is able to identify the changes 
in the calculation method of eGFR for any time series of 
eGFR and SCr measurements for a given patient. This 
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Figure 1. Changes in reporting of SCr and eGFR data over time
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method requires a time series of paired eGFR and SCr val-
ues for each patient, i.e. SCr and eGFR values are recorded 
simultaneously. We shall call this paired time series the renal 
function time series of the patient.
The eGFR method change finding algorithm
Each  laboratory uses a  function  (Mlab) to convert SCr mea-
surements (c) into eGFR values (glab). Thus
 glab = Mlab (c, cF) (1)
where CF represents  the patient-specific adjustment based 
on patient characteristics (age, gender and ethnicity). To 
identify  the  changes  in  Mlab,  we  defined  a  self-calculated 
eGFR (gself) generated using the MDRD equation (MMDRD) 
and using patient characteristics (CF) taken from the patient 
record
 gself = MMDRD (c, cF). (2)
We then defined a mapping function (Mu) that maps the self-
calculated eGFR onto the laboratory-calculated eGFR (Figure 2). 
The laboratory-calculated eGFR can, therefore, also be written as
 glab = Mu (gself ) (3)
The mapping function Mu will vary from the laboratory eGFR 
calculation function, Mlab. It is therefore possible to determine 
the number of laboratory Mlab functions by determining how 
many Mu functions are required to map the entire renal func-
tion  time series. We  identified  that Mu is a linear function in 
the logarithmic domain of its argument, glab and gself. Let us 
define the mapping function from log(glab) to log(gself) be Mu′. 
This function must be linear1, taking the form of
 
Mu′(log(glab)) = w1 log (gself ) + w0 (4)
1 The proof is omitted, but can be easily deduced from 
MDRD equations in the log domain.
where the parameters w1 and w0 can be found by the 
method of least square regression in the case of a single 
assay method and a mixture of regression28 in the case 
of multiple assay methods. By a mixture of regression, we 
mean  that  several  regression  lines  are  fitted  to  the  data 
simultaneously. Thus, if an eGFR series is composed of two 
different assay methods, two regression lines are needed to 
fit  the data. The  laboratory-calculated eGFR can therefore 
be obtained by
 glab = Mu (gself) = exp(w1 log (gself) + w0) (5)
Performing this mapping from gself onto glab for a series of two 
or more measurements enables w1 and w0 to be calculated.
SUBJECTS AND SETTING
We generated and tested the algorithm using anonymised 
patient records collected from 127 primary care practices 
across England; a total of nearly a million patient records 
(n =  951,764).  These  data  were  obtained  for  the  quality 
intervention in chronic kidney disease (QICKD) trial (clini-
cal  trials  registration:  ISRCTN56023731).4 These primary 
care samples comprise a nationally representative sam-
ple of urban, suburban and rural practices in localities 
within London, Surrey, Sussex, Leicester, Birmingham and 
Cambridge. The complete protocol used for sampling and 
data  collection  from  these  practices  for  the  QICKD  trial 
has been previously described. 29 In brief, routine clinical 
records were collected between June 2008 and December 
2010. All practices had the final data collection in December 
2010. All patients registered with the included practices 
at  the  time of  the first sampling period  (June 2008) were 
included in the data sample. Complete historical records 
were obtained for all these patients for a number of clini-
cal variables, including that data relating to renal function. 
All data were anonymised at the point of data extraction. 
Data from each practice were labelled with an anonymised 
practice ID number.
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Figure 2. The relationship between different variables. gself refers to the self-calculated eGFR using the MDRD; glab, the 
laboratory-calculated eGFR; c, SCr and M, different mapping functions. Both the MMDRD and Mlab also use ethnicity, age, and 
gender of the patient (not shown here)
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Research  Ethics  Committee  (Committee  C).  This  ethics 
approval included authorisation for secondary analysis of the 
QICKD data set.
RESULTS
A  total  of  1,309,337  unique  eGFR  measurements  were 
identified  in  the QICKD  database. The majority  (98.7%)  of 
eGFR values were recorded using an equation specific code 
(Table 1). No codes were identified in the read code system 
that enable recording of creatinine assay method.
The  951,764  patient  records  obtained  from  the  QICKD 
trial database were available for analysis. For this study, we 
used the top 20,000 patients who have the renal function time 
series with the highest number of paired eGFR and SCr val-
ues. These 20,000 people included had a median age of 74 
(interquartile range; IQR 64–81). 10,931 (54.7%) people were 
female. The median number of SCr measurements per per-
son was 22  (IQR 19–28) and  the median number of eGFR 
estimates 16 (IQR 13–20). 13,563 (67.8%) people had five or 
more SCr and laboratory-calculated eGFR values recorded 
simultaneously.
4736 (23.7%) people had two distinct detectable methods 
of calculation of eGFR from SCr. These methods always 
occurred sequentially with laboratories converting from one 
method to the other. We did not identify any patients with 
more than two methods of calculating eGFR.
By  grouping  patients  by  their  anonymised  practice  ID, 
we identified the range of dates between which the change 
in eGFR calculation method occurred for each practice 
To analyse the usage of eGFR codes we counted the total 
number of eGFR codes used in the primary care records of 
all 951,764 people included in the QICKD database.
To test our eGFR calculation change finding algorithm, we 
selected 20,000 patients with the most complete renal func-
tion time series in terms of the number of paired laboratory 
eGFR and SCr.
From the initial patient set, we excluded laboratory-
reported  values  of  eGFR  readings  exactly  equal  to  60  or 
90 mL/min because these values correspond to the capped 
thresholds chosen by certain laboratories. For example a 
laboratory using the 90 mL/min cap would report an eGFR 
of 93 mL/min as >90 mL/min; however, the ‘>’ sign can be 
lost in how the primary care computer system processes 
these data.
We  used  an  anonymised  practice  identification  number 
to group patients by practice. As all practices sent labora-
tory samples to a single laboratory, this change will affect all 
eGFR measurements reported by that practice, other than 
patients who move practice and have electronic transfer of 
their records. The latest identified value of the first calcula-
tion method and  the earliest  identified value of  the second 
method  in  each  practice  were  used  to  define  the  interval 
in which the change in method occurred. This is shown in 
Figure 3.
Ethical considerations
No  patient  identifiable  data  was  used  in  the  analysis  pre-
sented here. All the data were anonymised at the point of 
data extraction. The QICKD trial was approved by the Oxford 
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Figure 3. The date on which a laboratory might have changed its reporting assay method is taken as an interval defined by 
the latest value of the first time series and the earliest value of the second time series
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Figure 4. The estimated dates of eGFR calculation method change for practices where a change was detected in one or 
more patients within the practice. The range of uncertainty is shown for each practice using a horizontal line
(Figure 3). We identified a change in method in 114 (90%) of 
127 included practices.
The eGFR time series from patients who had stable 
renal function both before and after the change in labo-
ratory eGFR calculation method demonstrate a substan-
tial step change at the time of the change in method 
(Figure  4). Using  the MDRD  to  calculate  eGFR  from  the 
reported SCr measurements similarly demonstrates a dis-
continuity (Figure 5). Almost all of the step changes were 
an improvement in renal function. All of these changes 
occurred exactly at the time of change in eGFR calcula-
tion method. Both of these factors make this observation 
highly unlikely to be due to an actual physiological change 
in these patients.
DISCUSSION
Principal findings 
Our algorithm is able to detect changes in eGFR calculation 
method from a time series of eGFR and SCr measurements 
for any given patient. This change was detected in 23.7% of 
the people with the highest number of recorded renal function 
measurements. From these patient  records, we  identified a 
change in eGFR calculation method in 63% of the included 
practices  occurred  between  January  2006  and  December 
2010. There were no practices with more than two eGFR cal-
culation methods identified.
Changes in eGFR calculation method create a substan-
tial spurious step change in patient’s renal function at the 
Table 1. The 5 byte, version 2, read codes used for recording eGFR in the primary care records of 951,764 
people. The CKD-EPI read code was not available at the time these data were recorded
Read code Code rubric Number recorded (%)
451F Glomerular filtration rate. 16,317 (1.2)
451E Glomerular filtration rate calculated by abbreviated MDRD study group calculation. 1,292,572 (98.7)
451G Glomerular filtration rate calculated by abbreviated MDRD study group calculation adjusted for African American origin. 448 (0.04)
451K Estimated glomerular filtration rate using CKD-EPI formula. 0 (0.0)
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While we have focused primarily on the UK data here, the 
global use of an inhomogeneous mixture of creatinine assays 
prior to standardisation33 leads us to suggest that the spuri-
ous  step  changes  identified here are globally  ubiquitous  in 
historic data. 
Comparison with the literature 
To the  best of our knowledge, there have been no previous 
attempts to detect the time series artefacts we report using 
large-scale population data. The high level of background 
noise in eGFR measurements34 mean that these artefacts 
are not easily identified when observing the data using stand-
ard methods.
The importance of coding the context of blood glucose 
measurements has been previously noted although this call 
to improve standards has gone unheeded.35 Recording the 
context of eGFR measurements presents a similar problem. 
To effectively tackle this issue may require a change in the 
coding structure of existing coding systems.
Limitations of the method
The algorithm requires a minimum of two paired eGFR and 
SCr measurements before a change in eGFR calculation 
method and two after to correctly identify the change. This 
limits the population to which the method can be applied. 
However, in the data set in which additional information is 
known, such as the hospital or primary care centre where 
the test was performed, data from a few patients with a com-
plete renal function time series can be used to predict eGFR 
calculation method changes in the rest of the population.
In addition, this method cannot be applied to people 
with normal renal function as their exact eGFR values 
are  not  reported  (reported  as  either  >60  or  >90 ml/min). 
In practices, where a change in eGFR calculation method 
has been detected this change can be assumed to affect 
all members of that practice and could be used to calcu-
late and calibrate these capped values retrospectively. 
Furthermore, the exact value of eGFR for this population 
is of less importance given the poor reliability of eGFR in 
time of change in method. However, recalculating eGFR 
from SCr measurements does not remove this spurious 
step change. This suggests that the change in eGFR cal-
culation method is also associated with a change in creati-
nine assay. This is consistent with laboratories responding 
to the UKNEQAS recommendations to standardise to use 
the IDMS creatinine assay. 25
The type of equation used to calculate eGFR was gener-
ally well documented in the literature but there is currently no 
way of recording the creatinine assay method using the Read 
code system.
Implications of the findings
Both clinical decisions, such as when to refer to specialist ser-
vices, 8,9 are often based on renal function trends. Furthermore, 
there is an increasing amount of research utilising the routinely 
collected data. We have demonstrated that just under a quar-
ter of  renal  function  time series are subject  to spurious step 
changes in renal function as a result of changes in laboratory 
eGFR calculation methods and creatinine assay changes. If 
these artefactual changes in renal function are not considered 
in research or clinical decisions utilising longitudinal data of 
this type there is substantial potential for systematic error.
If the information on the type of equation and creatinine 
assay was required by the eGFR coding structure, these 
artefactual changes would be easy to identify and correct. 
However, although the current primary care coding system in 
the United Kingdom (Read codes) does allow this information 
to be recorded, this is rarely used. Future recording of eGFR 
should make use of such features to maximise the clinical 
and research utility of eGFR measurement and prevent spuri-
ous data from impacting on patient care.
Alternative coding schemes also have similar problems. 
For example, the Logical Observation Identifiers Names and 
Codes system for coding laboratory information, encodes 
results utilising a multi-dimensional approach with six major 
axes to define the clinical test.30 However the most commonly 
used creatinine codes (2160-0 and 38483-4) do not indicate 
which creatinine assay was used.31,32
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Figure 5. Two examples of selected patients with stable renal function. The change in eGFR calculation method (vertical 
line) can be seen to coincide with a step discontinuity in eGFR values
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people with good renal function. Nevertheless, it is still 
of interest to understand the trends in eGFR over time 
for  these patients  in order  to detect early stages of CKD 
progression.
The data used here are now over four years old, limiting 
the clinical utility of this method. However, this method is still 
important for research using longitudinal data. In addition, as 
laboratories  change  from using  the MDRD equation  to  the 
CKD-EPI equation there will be another period of laboratory 
eGFR calculation changes. Detection and elimination of the 
artefacts generated by this new change will be important both 
clinically and for future epidemiological research with a focus 
on renal function.
Call for further research 
Our method is the first step to generating a back-calibration 
algorithm that can correct for different eGFR calculation 
methods used by different  laboratories (Figure 6). Although 
direct application of the MDRD equation (or other equations) 
to recorded SCr measurements does not correct the mea-
surements (primary due to changes in creatinine assays 
used) this does not preclude the possibility of successfully 
calibrating these data.
CONCLUSIONS
This algorithm can identify laboratory changes in eGFR 
calculation methods. Failure to identify these changes 
in method may  cause misclassification  of  CKD  and mis-
construe renal function changes over time. While there 
is scope to improve clinical coding this can only be pro-
spective, and flagging the limitations of data at the time is 
important for future researchers if they are to derive most 
meaning from these data. Researchers using longitudinal 
routinely collected renal function data should account for 
these effects.
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Figure 6. Attempted back-calibration by applying the MDRD to the laboratory-reported creatinine values. Recalibration 
reduces (green) the apparent step discontinuity in these patients compared with the laboratory-reported eGFR values 
(black) but a considerable discrepancy is still evident. The patient data shown are the same as in Figure 5
REFERENCES
 1. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, 
Garmen A et al. Aging with multimorbidity: a systematic review 
of the literature. Ageing Research Reviews 2011;10(4):430–9. 
http://dx.doi.org/10.1016/j.arr.2011.03.003. PMid:21402176.
 2. Reutens  AT.  Epidemiology  of  diabetic  kidney  disease. 
Medical clinics of North America  2013;97(1):1–18.  Epub 
2013/01/08.  http://dx.doi.org/10.1016/j.mcna.2012.10.001. 
PMid:23290726.
 3. McGovern AP, Rusholme B, Jones S, van Vlymen JN, Liyanage 
H, Gallagher H et al. Association of chronic kidney disease 
(CKD) and  failure  to monitor  renal  function with adverse out-
comes  in  people  with  diabetes:  a  primary  care  cohort  study. 
BMc Nephrology  2013;14:198.  Epub  2013/09/21.  http://
dx.doi.org/10.1186/1471-2369-14-198.  PMid:24047312 
PMCid:PMC4015483.
 4. de Lusignan S, Gallagher H, Jones S, Chan T, van Vlymen J, 
Tahir A et al. Audit-based education lowers systolic blood 
 pressure  in  chronic  kidney  disease:  the  quality  improvement 
in CKD (QICKD) trial results. Kidney International 2013;84(3): 
609–20. Epub 2013/03/29. http://dx.doi.org/10.1038/ki.2013.96. 
PMid:23536132 PMCid:PMC3778715.
 5. Stevens PE, O’Donoghue DJ, de Lusignan S, Van Vlymen J, 
Klebe B, Middleton R et al. Chronic kidney disease manage-
ment in the United Kingdom: NEOERICA project results. Kidney 
International  2007;72(1):92–9.  http://dx.doi.org/10.1038/
sj.ki.5002273. PMid:17440495.
 6. Kerr M, Bray B, Medcalf J, O’Donoghue DJ and Matthews B. 
Estimating the financial cost of chronic kidney disease to the 
NHS in England. Nephrology Dialysis Transplantation 2012;27 
Suppl 3:iii73–80. Epub 2012/07/21. http://dx.doi.org/10.1093/
ndt/gfs269. PMid:22815543 PMCid:PMC3484716.
 7. Cockcroft  DW  and  Gault  MH.  Prediction  of  creatinine  clear-
ance from serum creatinine. Nephron 1976;16(1):31–41. Epub 
1976/01/01. http://dx.doi.org/10.1159/000180580.
Journal of Innovation in Health Informatics Vol 22, No 2 (2015)
Poh et al. Improving the measurement of longitudinal change in renal function  300
 8. National Institute for Health and Clinical Excellence. Early iden-
tification and management of chronic kidney disease in adults 
in primary and secondary care: Clinical Guideline 732008. URL: 
http://www.nice.org.uk/cg73.
 9. National  Kidney  Foundation.  K/DOQI  clinical  practice  guide-
lines for chronic kidney disease: evaluation, classification, and 
stratification. American Journal of Kidney Diseases 2002;39(2 
Suppl 1):S1–266. Epub 2002/03/21. PMid:11904577.
 10. Wargo  KA  and  English TM.  Evaluation  of  the  chronic  kidney 
disease epidemiology collaboration equation for dosing anti-
microbials. Annals of Pharmacotherapy  2010;44(3):439–46. 
Epub  2010/02/19.  http://dx.doi.org/10.1345/aph.1M602. 
PMid:20164470.
 11. Jones  GR.  Estimating  renal  function  for  drug  dosing  deci-
sions. The clinical Biochemist Reviews 2011;32(2):81–8. Epub 
2011/05/26. PMid:21611081 PMCid:PMC3100285.
 12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N and 
Roth  D. A  more  accurate  method  to  estimate  glomerular  fil-
tration rate  from serum creatinine: a new prediction equation. 
Modification  of  Diet  in  Renal  Disease  Study  Group.  Annals 
of Internal Medicine  1999;130(6):461–70.  Epub  1999/03/13. 
http://dx.doi.org/10.7326/0003-4819-130-6-199903160-00002. 
PMid:10075613.
 13. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. 
National Kidney Foundation practice guidelines for chronic kid-
ney disease: evaluation, classification, and stratification. Annals 
of Internal Medicine  2003;139(2):137–47.  Epub  2003/07/16. 
http://dx.doi.org/10.7326/0003-4819-139-2-200307150-00013. 
PMid:12859163.
 14. Coresh J and Stevens LA. Kidney function estimating equa-
tions:  where  do  we  stand?  current Opinion in Nephrology 
and Hypertension  2006;15(3):276–84.  Epub  2006/04/13. 
http://dx.doi.org/10.1097/01.mnh.0000222695.84464.61. 
PMid:16609295.
 15. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ 
and Cosio FG. Using serum creatinine to estimate glomerular 
filtration  rate:  accuracy  in  good  health  and  in  chronic  kidney 
disease. Annals of Internal Medicine  2004;141(12):929–37. 
Epub 2004/12/22. http://dx.doi.org/10.7326/0003-4819-141-12-
200412210-00009. PMid:15611490.
 16. Ibrahim H, Mondress M, Tello A, Fan Y, Koopmeiners J and 
Thomas W. An alternative formula to the Cockcroft–Gault and 
the modification of diet in renal diseases formulas in predicting 
GFR in individuals with type 1 diabetes. Journal of American 
Society of Nephrology 2005;16(4):1051–60. Epub 2005/02/18. 
http://dx.doi.org/10.1681/ASN.2004080692. PMid:15716336.
 17. Poggio  ED,  Wang  X,  Greene  T,  Van  Lente  F  and  Hall  PM. 
Performance  of  the modification  of  diet  in  renal  disease  and 
Cockcroft–Gault equations  in  the estimation of GFR  in health 
and in chronic kidney disease. Journal of American Society 
of Nephrology.  2005;16(2):459–66.  Epub  2004/12/24.  http://
dx.doi.org/10.1681/ASN.2004060447. PMid:15615823.
 18. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro 
AF,  3rd,  Feldman  HI  et  al.  A  new  equation  to  estimate 
glomerular  filtration  rate.  Annals of Internal Medicine 
2009;150(9):604–12.  Epub  2009/05/06.  http://dx.doi.
o rg /10 .7326 /0003 -4819 -150 -9 -200905050 -00006 . 
PMid:19414839 PMCid:PMC2763564.
 19. Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, 
Froissart  M  et  al.  Comparative  performance  of  the  CKD 
Epidemiology  Collaboration  (CKD-EPI)  and  the  Modification 
of Diet in Renal Disease (MDRD) Study equations for estimat-
ing GFR  levels above 60 mL/min/1.73 m2. American Journal 
of Kidney Diseases  2010;56(3):486–95.  Epub  2010/06/19. 
http://dx.doi.org/10.1053/j.ajkd.2010.03.026.  PMid:20557989 
PMCid:PMC2926290.
 20. Stevens  LA,  Schmid  CH,  Zhang  YL,  Coresh  J,  Manzi  J, 
Landis R et al. Development and validation of GFR-estimating 
equations using diabetes, transplant and weight. Nephrology 
Dialysis Transplantation 2010;25(2):449–57. Epub 2009/10/02. 
http://dx.doi.org/10.1093/ndt/gfp510.  PMid:19793928 
PMCid:PMC2910328.
 21. Kilbride HS, Stevens PE, Eaglestone G, Knight S, Carter JL, 
Delaney MP et al. Accuracy of the MDRD (Modification of Diet 
in  Renal  Disease)  study  and  CKD-EPI  (CKD  Epidemiology 
Collaboration) equations for estimation of GFR in the elderly. 
American Journal of Kidney Diseases 2013;61(1):57–66. Epub 
2012/08/15.  http://dx.doi.org/10.1053/j.ajkd.2012.06.016. 
PMid:22889713.
 22. Van Biesen W, Vanholder R, Veys N, Verbeke F, Delanghe J, 
De Bacquer D et al. The importance of standardization of cre-
atinine in the implementation of guidelines and recommenda-
tions for CKD: implications for CKD management programmes. 
Nephrology Dialysis Transplantation  2006;21(1):77–83. 
Epub  2005/10/14.  http://dx.doi.org/10.1093/ndt/gfi185. 
PMid:16221704.
 23. Vervoort  G,  Klein  Gunnewiek  JM,  Willems  HL  and  Wetzels 
JF.  Effect  of  creatinine  assay  standardization  on  the  perfor-
mance  of  Cockcroft–Gault  and  MDRD  formula  in  predicting 
GFR. Nephrology Dialysis Transplantation 2006;21(10):2998–9.  
Epub  2006/06/01.  http://dx.doi.org/10.1093/ndt/gfl276. 
PMid:16735385.
 24. Poh N, Rattani A and Roli F. Critical analysis of adaptive bio-
metric systems. Biometrics  2012;1(4):179–87.  http://dx.doi.
org/10.1049/iet-bmt.2012.0019.
 25. de Lusignan S, Gallagher H, Stevens P, Harris K and 
O’Donoghue D. Chronic kidney disease frequently asked ques-
tions,  2010.  URL:  http://www.britishrenal.org/getattachment/
CKD-Forum/Clinical-Managment/CKD-FAQs-(DH-Jan-2010).
pdf.
 26. Carter JL, Stevens PE, Irving JE and Lamb EJ. Estimating glo-
merular filtration rate: comparison of the CKD-EPI and MDRD 
equations in a large UK cohort with particular emphasis on 
the effect of age. QJM : Monthly Journal of the Association 
of Physicians  2011;104(10):839–47.  Epub  2011/06/10.  http://
dx.doi.org/10.1093/qjmed/hcr077. PMid:21652537
 27. de  Lusignan  S.  Codes,  classifications,  terminologies  and 
nomenclatures:  definition,  development  and  application  in 
practice. Informatics in Primary care 2005;13(1):65–70. Epub 
2005/06/14. PMid:15949178.
 28. Friedberg M, Hussey P and Schneider E. Primary care: a criti-
cal review of the evidence on quality and costs of health care. 
Journal of Innovation in Health Informatics Vol 22, No 2 (2015)
Poh et al. Improving the measurement of longitudinal change in renal function  301
Health Affairs  2010;29(5):766–72.  http://dx.doi.org/10.1377/
hlthaff.2010.0025. PMid:20439859.
 29. de Lusignan S, Gallagher H, Chan T, Thomas N, van Vlymen J, 
Nation M  et al. The QICKD study protocol: a cluster randomised trial 
to compare quality improvement interventions to lower systolic BP 
in chronic kidney disease (CKD) in primary care. Implementation 
Science  2009;4:39.  http://dx.doi.org/10.1186/1748-5908-4-39. 
PMid:19602233 PMCid:PMC2719588.
 30. McDonald  C,  Huff  S,  deckard  J,  Holck  K  and  Vreeman  DJ. 
Logical  Observation  Identifiers  Names  and  Codes  (LOINC) 
Users’  Guide.  Regenstrief  Institute;  2014  [Accessed:  02  Oct 
2014]; URL: http://loinc.org/documentation.
 31. Vatsa M,  Singh  R,  Ross A  and  Noore A.  Biometric  classifier 
update using online learning: a case study in near infrared face 
verification. Image and Vision computing 2010.
 32. Didaci  L,  Marcialis  GL  and  Roli  F.  A Theoretical And 
Experimental Analysis Of Template co-Update In Biometric 
Verification Systems. Berlin, Germany: Springer.
 33. Nyman HA, Dowling TC, Hudson JQ, Peter WL, Joy MS and 
Nolin TD. Comparative evaluation of the Cockcroft–Gault equa-
tion  and  the  Modification  of  Diet  in  Renal  Disease  (MDRD) 
study equation  for drug dosing: an opinion of  the Nephrology 
Practice and Research Network of the American College of 
Clinical Pharmacy. Pharmacotherapy  2011;31(11):1130–44. 
Epub  2011/10/27.  http://dx.doi.org/10.1592/phco.31.11.1130. 
PMid:22026399.
 34. Poh  N  and  de  Lusignan  S.  Data-modelling  and  visualisation 
in chronic kidney disease (CKD): a step towards personalised 
medicine. Informatics in Primary care 2011;19(2):57–63. Epub 
2011/01/01. PMid:22417815.
 35. de  Lusignan  S.  Flagging  fasting  plasma  glucose  specimens: 
time to routinely label the context in which pathology specimens 
are recorded. Informatics in Primary care  2009;17(2):63–4. 
Epub 2009/10/08. PMid:19807947.
